Preeti Vaishnav
Molecular Biology · 2009–2011
A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 9 citations into it
- Biotechnology — 5 citations into it
Whom Preeti Vaishnav trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Preeti Vaishnav's perspective
Ordered by how strongly the researchers Preeti Vaishnav trusts endorse each paper. Same corpus, a different order for every researcher.
- Plants and human health in the twenty-first century. (Trends in Biotechnology)
- Identification of selective inhibitors of cancer stem cells by high-throughput screening (Cell)
- Secretory and extracellular production of recombinant proteins using Escherichia coli (Applied Microbiology and Biotechnology)
- Molecular genetic strain improvement for the overproduction of fungal proteins by Filamentous fungi (Applied Microbiology and Biotechnology)
- Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor (Nature Medicine)
- Biopharmaceutical benchmarks (Nature Biotechnology)
- Plants as a source of anti-cancer agents. (Journal of Ethnopharmacology)
- Natural compounds for cancer treatment and prevention. (Pharmacological Research)
- Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems (Applied Microbiology and Biotechnology)
- Natural products in drug discovery. (Drug Discovery Today)
Their papers
- Natural products for cancer chemotherapy (2011) — 633 citations
- Production of recombinant proteins by microbes and higher organisms. (2009) — 1,020 citations